Delayed initiation of broad-spectrum gram-negative antibiotic therapy was not linked to worse clinical outcomes among adult inpatients.

The US Food and Drug Administration (FDA) has approved a new antibiotic, PAQFLOR, for use with finfish. PAQFLOR, a ...

Clinical outcomes among adult inpatients were no worse when broad-spectrum antibiotic therapy was delayed vs started early, challenging the belief that overly broad-spectrum empiric antibiotic ...